News

MEGIN attends ILAE with strategic partner BESA, shares new Spotlight and Masterclass for September, and research papers on epilepsy, women’s health and Alzheimer’s Disease.

Meet MEGIN, and strategic partner BESA, at IEC 2025 in Lisbon, Portugal. MEGIN attends MEG UKI and completes training at East China Normal University.

MEGIN starts training and installation of MEG Maps and installs a new TRIUX™ neo site at Shanghai 9th People’s Hospital

MEGIN upgrades University of Trento to TRIUX™ neo and the team attends international MEG conferences and events.

MYndspan launches crowdfunding round. MEGIN shares new Masterclass, features in Customer Community, and sponsored events in April and May.

MYndspan and MEGIN partner to make MEG brain scans more accessible. MEGIN receives “Pioneer in Technology Development” award from The SBMT

We were proud to join our strategic partners BESA GmbH at Arab Health this January! MEGIN, together with Aalto University, publishes research that could streamline MEG/EEG source imaging.

As we begin 2025, MEGIN is excited to continue our commitment to innovation, excellence, and collaboration to further MEG in neuroscience.

This year at MEGIN we celebrated the launch of our new MEG Maps™ platform*, installed new sites, and strengthened our strategic partnerships.

MEGIN is delighted to be offering workshop sessions at AES with our strategic partners and early adopter, exploring our new MEG Maps™ Platform*.

Norman Fixel Institute for Neurological Diseases at University of Florida Health, celebrates 1 year of the TRIUX™ neo scanner and their 100th MEG scan!

MEGIN team members present their work at BIOMAG 2024 in Sydney and we attend ASFNR with one of our strategic partners, FIND Neuro.

MEGIN begins to offer demos of the MEG Maps™ platform at events, and heads out to Boston to support the Pediatric Epilepsy Surgery Alliance (PESA) family conference.

MEGIN achieves new FDA 510(k) clearance for all components of MEG Maps™ and is featured in a video showing the cutting-edge installations now operational at Campus Biotech in Geneva.